Tower Research Capital LLC (Trc) Dexcom Inc Transaction History

Tower Research Capital LLC (Trc)

$4.07 Billion
Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Dexcom Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 32,025 shares of DXCM stock, worth $3.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

32,025

Previous 62,700 48.92%

Holding current value

$3.6 Million

Previous $7.78 Million 42.92%

% of portfolio

0.11%

Previous 0.1%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $3.5 Million - $4.3 Million	-30,675 Reduced 48.92%	32,025 $4.44 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $396,775 - $652,584	5,256 Added 9.15%	62,700 $7.78 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $4.22 Million - $6.77 Million	49,052 Added 584.51%	57,444 $5.36 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $71,980 - $83,827	640 Added 8.26%	8,392 $1.08 Million
Q1 2023 May 09, 2023	SELL	$104.0 - $122.92 $757,328 - $895,103	-7,282 Reduced 48.44%	7,752 $900,000

Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $6.7 Million - $9.67 Million	-78,814 Reduced 83.98%	15,034 $1.7 Million
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $3.33 Million - $4.11 Million	43,590 Added 86.73%	93,848 $7.56 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $1.62 Million - $3.17 Million	23,875 Added 90.49%	50,258 $3.75 Million
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $1.55 Million - $2.15 Million	16,489 Added 166.66%	26,383 $13.5 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $518,311 - $649,814	3,991 Added 67.61%	9,894 $5.31 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $275,738 - $369,977	2,584 Added 77.85%	5,903 $3.23 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $753,207 - $1 Million	-9,300 Reduced 73.7%	3,319 $1.42 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $914,375 - $1.13 Million	10,784 Added 587.68%	12,619 $4.54 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $236,964 - $317,471	-3,038 Reduced 62.34%	1,835 $678,000
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $274,686 - $324,844	2,876 Added 144.02%	4,873 $2.01 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $121,849 - $204,780	1,944 Added 3667.92%	1,997 $810,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $2,532 - $4,008	53 New	53 $14,000
Q4 2019 Feb 07, 2020	SELL	$36.62 - $57.29 $50,352 - $78,773	-1,375 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$35.53 - $43.8 $48,853 - $60,224	1,375 New	1,375 $205,000
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $58,965 - $82,432	-2,118 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $59,452 - $80,865	2,118 New	2,118 $252,000
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $101,455 - $140,473	-3,759 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$23.35 - $36.72 $52,981 - $83,317	2,269 Added 152.28%	3,759 $538,000
Q2 2018 Aug 15, 2018	SELL	$17.54 - $25.22 $5,174 - $7,439	-295 Reduced 16.53%	1,490 $142,000
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $23,312 - $33,093	1,785 New	1,785 $132,000

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

353M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Dexcom Inc Transaction History